Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1852 1
1921 1
1925 1
1930 1
1946 2
1948 1
1949 2
1950 2
1951 2
1953 3
1954 1
1955 4
1956 3
1957 2
1959 4
1960 9
1961 2
1962 1
1964 2
1965 3
1966 4
1967 5
1968 3
1969 5
1970 3
1971 5
1972 4
1973 4
1974 5
1975 6
1976 5
1977 3
1978 9
1979 9
1980 10
1981 8
1982 11
1983 15
1984 10
1985 11
1986 20
1987 15
1988 8
1989 11
1990 19
1991 16
1992 19
1993 29
1994 26
1995 26
1996 15
1997 30
1998 32
1999 28
2000 34
2001 45
2002 51
2003 42
2004 41
2005 82
2006 69
2007 62
2008 82
2009 93
2010 122
2011 125
2012 141
2013 146
2014 145
2015 142
2016 153
2017 174
2018 183
2019 176
2020 214
2021 271
2022 291
2023 276
2024 97

Text availability

Article attribute

Article type

Publication date

Search Results

3,396 results

Results by year

Filters applied: . Clear all
Page 1
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Hamdy FC, Donovan JL, Lane JA, Metcalfe C, Davis M, Turner EL, Martin RM, Young GJ, Walsh EI, Bryant RJ, Bollina P, Doble A, Doherty A, Gillatt D, Gnanapragasam V, Hughes O, Kockelbergh R, Kynaston H, Paul A, Paez E, Powell P, Rosario DJ, Rowe E, Mason M, Catto JWF, Peters TJ, Oxley J, Williams NJ, Staffurth J, Neal DE; ProtecT Study Group. Hamdy FC, et al. Among authors: paul a. N Engl J Med. 2023 Apr 27;388(17):1547-1558. doi: 10.1056/NEJMoa2214122. Epub 2023 Mar 11. N Engl J Med. 2023. PMID: 36912538 Clinical Trial.
Multimodal deep learning for Alzheimer's disease dementia assessment.
Qiu S, Miller MI, Joshi PS, Lee JC, Xue C, Ni Y, Wang Y, De Anda-Duran I, Hwang PH, Cramer JA, Dwyer BC, Hao H, Kaku MC, Kedar S, Lee PH, Mian AZ, Murman DL, O'Shea S, Paul AB, Saint-Hilaire MH, Alton Sartor E, Saxena AR, Shih LC, Small JE, Smith MJ, Swaminathan A, Takahashi CE, Taraschenko O, You H, Yuan J, Zhou Y, Zhu S, Alosco ML, Mez J, Stein TD, Poston KL, Au R, Kolachalama VB. Qiu S, et al. Among authors: paul ab. Nat Commun. 2022 Jun 20;13(1):3404. doi: 10.1038/s41467-022-31037-5. Nat Commun. 2022. PMID: 35725739 Free PMC article.
Electrocardiographic lead reversals.
Paul A, Jacob JR. Paul A, et al. Indian Pacing Electrophysiol J. 2023 Nov-Dec;23(6):205-213. doi: 10.1016/j.ipej.2023.09.005. Epub 2023 Sep 20. Indian Pacing Electrophysiol J. 2023. PMID: 37739313 Free PMC article. Review.
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
Verma A, Shteinfer-Kuzmine A, Kamenetsky N, Pittala S, Paul A, Nahon Crystal E, Ouro A, Chalifa-Caspi V, Pandey SK, Monsonego A, Vardi N, Knafo S, Shoshan-Barmatz V. Verma A, et al. Among authors: paul a. Transl Neurodegener. 2022 Dec 28;11(1):58. doi: 10.1186/s40035-022-00329-7. Transl Neurodegener. 2022. PMID: 36578022 Free PMC article.
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.
Wu Z, Chen Q, Qu L, Li M, Wang L, Mir MC, Carbonara U, Pandolfo SD, Black PC, Paul AK, Di Lorenzo G, Porpiglia F, Mari A, Necchi A, Rouprêt M, Psutka SP, Autorino R. Wu Z, et al. Among authors: paul ak. Eur Urol. 2022 Apr;81(4):414-425. doi: 10.1016/j.eururo.2022.01.028. Epub 2022 Jan 31. Eur Urol. 2022. PMID: 35101302 Free article. Review.
Transcriptome-based identification of tumor-reactive and bystander CD8+ T cell receptor clonotypes in human pancreatic cancer.
Meng Z, Rodriguez Ehrenfried A, Tan CL, Steffens LK, Kehm H, Zens S, Lauenstein C, Paul A, Schwab M, Förster JD, Salek M, Riemer AB, Wu H, Eckert C, Leonhardt CS, Strobel O, Volkmar M, Poschke I, Offringa R. Meng Z, et al. Among authors: paul a. Sci Transl Med. 2023 Nov 15;15(722):eadh9562. doi: 10.1126/scitranslmed.adh9562. Epub 2023 Nov 15. Sci Transl Med. 2023. PMID: 37967201
Einfache Leberzysten.
Dancs PT, Hoyer DP, Paul A. Dancs PT, et al. Among authors: paul a. Zentralbl Chir. 2022 Apr;147(2):129-131. doi: 10.1055/a-1546-2684. Epub 2022 Apr 4. Zentralbl Chir. 2022. PMID: 35378549 German. No abstract available.
Architects of Pituitary Tumour Growth.
Sabatino ME, Grondona E, De Paul AL. Sabatino ME, et al. Among authors: de paul al. Front Endocrinol (Lausanne). 2022 Jun 28;13:924942. doi: 10.3389/fendo.2022.924942. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35837315 Free PMC article. Review.
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Lane JA, Donovan JL, Young GJ, Davis M, Walsh EI, Avery KNL, Blazeby JM, Mason MD, Martin RM, Peters TJ, Turner EL, Wade J, Bollina P, Catto JWF, Doherty A, Gillatt D, Gnanapragasam V, Hughes O, Kockelbergh R, Kynaston H, Oxley J, Paul A, Paez E, Rosario DJ, Rowe E, Staffurth J, Neal DE, Hamdy FC, Metcalfe C; Prostate Testing for Cancer and Treatment (ProtecT) Study Group. Lane JA, et al. Among authors: paul a. BJU Int. 2022 Sep;130(3):370-380. doi: 10.1111/bju.15739. Epub 2022 May 3. BJU Int. 2022. PMID: 35373443 Free PMC article. Clinical Trial.
3,396 results